<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy - Hughes, RAC - 2017 | Cochrane Library</title> <meta content="Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy - Hughes, RAC - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002062.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy - Hughes, RAC - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002062.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD002062.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy" name="citation_title"/> <meta content="Richard AC Hughes" name="citation_author"/> <meta content="National Hospital for Neurology and Neurosurgery" name="citation_author_institution"/> <meta content="rhughes11@btinternet.com" name="citation_author_email"/> <meta content="Man Mohan Mehndiratta" name="citation_author"/> <meta content="Janakpuri Superspecialty Hospital" name="citation_author_institution"/> <meta content="Yusuf A Rajabally" name="citation_author"/> <meta content="Aston University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD002062.pub4" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/11/29" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002062.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002062.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002062.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti‐Inflammatory Agents [*therapeutic use]; Dexamethasone [therapeutic use]; Glucocorticoids [*therapeutic use]; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating [*drug therapy]; Prednisolone [therapeutic use]; Prednisone [therapeutic use]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002062.pub4&amp;doi=10.1002/14651858.CD002062.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="Qh5938oe";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD002062\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD002062\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002062\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002062\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","fa","ru"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD002062.pub4",title:"Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy",firstPublishedDate:"Nov 29, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neuromuscular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Qh5938oe&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002062.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD002062.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD002062.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD002062.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002062.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD002062.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD002062.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD002062.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD002062.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD002062.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3540 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD002062.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/full#CD002062-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/full#CD002062-sec-0071"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/full#CD002062-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/full#CD002062-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/full#CD002062-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/full#CD002062-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/full#CD002062-sec-0048"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/full#CD002062-sec-0061"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/appendices#CD002062-sec-0076"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/table_n/CD002062StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/table_n/CD002062StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/information#CD002062-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Richard AC Hughes</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/information#CD002062-cr-0003">Man Mohan Mehndiratta</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002062.pub4/information#CD002062-cr-0004">Yusuf A Rajabally</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/information/en#CD002062-sec-0085">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 29 November 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD002062.pub4">https://doi.org/10.1002/14651858.CD002062.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD002062-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002062-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD002062-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD002062-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD002062-abs-0005">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD002062-abs-0001" lang="en"> <section id="CD002062-sec-0001"> <h3 class="title" id="CD002062-sec-0001">Background</h3> <p>Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive or relapsing and remitting paralysing illness, probably due to an autoimmune response, which should benefit from corticosteroid treatment. Non‐randomised studies suggest that corticosteroids are beneficial. Two commonly used corticosteroids are prednisone and prednisolone. Both are usually given as oral tablets. Prednisone is converted into prednisolone in the liver so that the effect of the two drugs is usually the same. Another corticosteroid, dexamethasone, is more potent and is used in smaller doses. The review was first published in 2001 and last updated in 2015; we undertook this update to identify any new evidence. </p> </section> <section id="CD002062-sec-0002"> <h3 class="title" id="CD002062-sec-0002">Objectives</h3> <p>To assess the effects of corticosteroid treatment for CIDP compared to placebo or no treatment, and to compare the effects of different corticosteroid regimens. </p> </section> <section id="CD002062-sec-0003"> <h3 class="title" id="CD002062-sec-0003">Search methods</h3> <p>On 8 November 2016, we searched the Cochrane Neuromuscular Specialised Register, Cochrane Central Register of Controlled Trials, MEDLINE, and Embase for randomised trials of corticosteroids for CIDP. We searched clinical trials registries for ongoing trials. </p> </section> <section id="CD002062-sec-0004"> <h3 class="title" id="CD002062-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) or quasi‐RCTs of treatment with any corticosteroid or adrenocorticotrophic hormone for CIDP, diagnosed by an internationally accepted definition. </p> </section> <section id="CD002062-sec-0005"> <h3 class="title" id="CD002062-sec-0005">Data collection and analysis</h3> <p>Two authors extracted data from included studies and assessed the risk of bias independently. The intended primary outcome was change in disability, with change in impairment after 12 weeks and side effects as secondary outcomes. We assessed strength of evidence using the GRADE approach. </p> </section> <section id="CD002062-sec-0006"> <h3 class="title" id="CD002062-sec-0006">Main results</h3> <p>One non‐blinded RCT comparing prednisone with no treatment in 35 eligible participants did not measure the primary outcome for this systematic review. The trial had a high risk of bias. Neuropathy Impairment Scale scores after 12 weeks improved in 12 of 19 participants randomised to prednisone, compared with five of 16 participants randomised to no treatment (risk ratio (RR) for improvement 2.02 (95% confidence interval (CI) 0.90 to 4.52; very low‐quality evidence). The trial did not report side effects in detail, but one prednisone‐treated participant died. </p> <p>A double‐blind RCT comparing daily standard‐dose oral prednisolone with monthly high‐dose oral dexamethasone in 40 participants reported none of the prespecified outcomes for this review. The trial had a low risk of bias, but the quality of evidence was limited as it came from a single small study. There was little or no difference in number of participants who achieved remission (RR 1.11; 95% CI 0.50 to 2.45 in favour of monthly dexamethasone; moderate‐quality evidence), or change in disability or impairment after one year (low‐quality evidence). Change of grip strength or Medical Research Council (MRC) scores demonstrated little or no difference between groups (moderate‐quality to low‐quality evidence). Eight of 16 people in the prednisolone group and seven of 24 people in the dexamethasone group deteriorated. Side effects were similar with each regimen, except that sleeplessness was less common with monthly dexamethasone (low‐quality evidence) as was moon facies (moon‐shaped appearance of the face) (moderate‐quality evidence). </p> <p>Experience from large non‐randomised studies suggests that corticosteroids are beneficial, but long‐term use causes serious side effects. </p> </section> <section id="CD002062-sec-0007"> <h3 class="title" id="CD002062-sec-0007">Authors' conclusions</h3> <p>We are very uncertain about the effects of oral prednisone compared with no treatment, because the quality of evidence from the only RCT that exists is very low. Nevertheless, corticosteroids are commonly used in practice, supported by very low‐quality evidence from observational studies. We also know from observational studies that corticosteroids carry the long‐term risk of serious side effects. The efficacy of high‐dose monthly oral dexamethasone is probably little different from that of daily standard‐dose oral prednisolone. Most side effects occurred with similar frequencies in both groups, but with high‐dose monthly oral dexamethasone moon facies is probably less common and sleeplessness may be less common than with oral prednisolone. We need further research to identify factors that predict response. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD002062-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002062-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD002062-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD002062-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ru#CD002062-abs-0009">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD002062-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD002062-abs-0003" lang="en"> <h3>Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy</h3> <p><b>Review question</b> </p> <p>We reviewed the evidence about the benefits and harms of using corticosteroids for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). </p> <p><b>Background</b> </p> <p>CIDP is an uncommon paralysing disease that occurs when nerves outside the brain and spinal cord become inflamed. It produces slowly evolving weakness and numbness of the limbs. Some people have recurrent periods of worsening followed by improvement or remission. We wanted to discover the answers to two questions: firstly, whether use of corticosteroids is helpful; and secondly, whether one type of corticosteroid treatment is better than another. This is an update of a review first published in 2001 and last updated in 2014. </p> <p><b>Study characteristics</b> </p> <p>We found one randomised controlled trial (RCT) addressing each question. We did not find any new trials for this update. </p> <p>A 1982 US study compared daily prednisone tablets for 12 weeks with no treatment. Thirty‐five people took part. Fourteen participants received prednisone (10 male and four female, with a median age of 46.5 years) and 14 did not receive prednisone (nine male and five female, with a median age of 50 years). Those taking part and the trialists were aware of which treatment the participants received (i.e. they were not 'blinded'), which carries a risk of bias. </p> <p>The second study compared two six‐month corticosteroid treatment regimens: daily standard‐dose prednisolone tablets, and high‐dose dexamethasone tablets for four days each month. Multiple European centres did the trial, which reported its findings in 2010. Forty‐one people took part but one person withdrew after one day because they did not want to continue and the diagnosis was wrong. Of those who continued, 24 (18 men and six women, average age 59.9 years) received monthly dexamethasone and 16 (10 men and six women, average age 60.8 years) received daily prednisolone. </p> <p>There was no commercial support for either study. Funding for both came from an academic centre or charitable funds. </p> <p><b>Key results</b> </p> <p>Neither included study reported our preferred primary outcome, which was a disability score. </p> <p>After 12 weeks, in the trial of prednisone compared to no treatment, 12 of 19 participants on prednisone improved compared with five of 16 participants not on prednisone, based on measurement of disease severity by neurologists. Thus, improvement was about twice as common with prednisone. The small numbers in the trial and its limitations meant that even with this difference we are very uncertain about the size of any effect of prednisone. The trial authors did not report side effects in detail, but one person who received prednisone died. Corticosteroids are commonly used for CIDP in practice, based on favourable reports from non‐randomised studies. Corticosteroids are well known to cause side effects, especially when people take large doses for a long time. </p> <p>In the RCT comparing two corticosteroid regimens, 10 of 24 people on monthly dexamethasone and six of 16 people on daily prednisolone were well and off treatment after a year, which indicates effects that are probably similar. Changes in grip strength and scores of muscle strength were also probably similar between the treatment groups. Monthly dexamethasone and daily prednisolone had similar side effects to one another, except that with high‐dose monthly dexamethasone, sleeplessness may be less common and a moon‐shaped facial appearance is probably less common. </p> <p><b>Quality of the evidence</b> </p> <p>The benefit and harm from prednisone in CIDP is uncertain. The quality of evidence is very low because only one small randomised trial with a high risk of bias is available. </p> <p>Monthly dexamethasone and daily prednisolone may be of similar benefit in CIDP, but monthly dexamethasone may have fewer side effects. </p> <p><b>Date</b> </p> <p>The evidence is up to date to 8 November 2016.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD002062-sec-0071" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD002062-sec-0071"></div> <h3 class="title" id="CD002062-sec-0072">Implications for practice</h3> <section id="CD002062-sec-0072"> <p>We are very uncertain about the effects of prednisone in comparison to no treatment in chronic inflammatory demyelinating polyradiculoneuropathy as the quality of evidence is very low. Nevertheless, corticosteroids are commonly used in practice, supported by very low‐quality evidence from observational studies and apparent clinical efficacy in day‐to‐day use. Corticosteroids are known from observational studies to carry the long‐term risk of serious side effects. High‐dose monthly oral dexamethasone probably has similar efficacy to daily oral prednisolone. Both cause short‐term side effects, but sleeplessness may be less common and moon facies is probably less common with monthly dexamethasone. </p> </section> <h3 class="title" id="CD002062-sec-0073">Implications for research</h3> <section id="CD002062-sec-0073"> <p>Further research is needed to identify factors which predict response and deterioration after corticosteroids. Randomised controlled trials are urgently needed to discover whether corticosteroids are cost effective compared with other treatments, especially intravenous immunoglobulin, and whether adjunctive treatment with immunosuppressive agents is superior to corticosteroids alone. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD002062-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD002062-sec-0029"></div> <div class="table" id="CD002062-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Prednisone for chronic inflammatory demyelinating polyradiculoneuropathy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Prednisone for chronic inflammatory demyelinating polyradiculoneuropathy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with chronic inflammatory demyelinating polyradiculoneuropathy<br/> <b>Settings:</b> hospital specialist neurological outpatient department<br/> <b>Intervention:</b> prednisone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk or value</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk or value</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control (no treatment)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Prednisone</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Change in disability after one year</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in impairment after 12 weeks (excluding those who did not complete the study)</b><br/> NIS score (range 0 to 280) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean improvement in impairment after 12 weeks, excluding those who did not complete the study in the control group was<br/> 3.5 points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean improvement in impairment after 12 weeks, excluding those who did not complete the study in the prednisone group was<br/> <b>17.14 points higher</b><br/> (4.39 lower to 38.67 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in impairment after 12 weeks (including those who did not complete the study)</b><br/> NIS (range 0 to 280) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean improvement in impairment after 12 weeks, including those who did not complete the study in the control group was<br/> ‐ 2.4 points (i.e. 2.4 points worse) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean improvement in impairment after 12 weeks, including those who did not complete the study in the prednisone group was<br/> <b>11.6 points higher</b><br/> (9.39 lower to 32.58 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants improved after 12 weeks (excluding those who did not complete the study)</b><br/> NIS score (range 0 to 280) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>357 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>857 per 1000</b><br/> (411 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.40</b> <br/> (CI 1.15 to 5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statistically significant more improvement, but at high risk of bias</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants improved after 12 weeks (including those who did not complete the study)</b><br/> NIS (range 0 to 280) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>312 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>631 per 1000</b><br/> (281 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.02</b> <br/> (CI 0.9 to 4.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>NIS</b> : Neuropathy Impairment Scale; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded the quality of evidence three times: twice for very serious study limitations and once for imprecision. The trial was not blinded and randomisation was not concealed. The 95% CI were wide. <br/> <sup>2</sup>Seven participants were excluded, giving high risk of bias in favour of prednisone. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD002062-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Monthly pulsed high‐dose dexamethasone compared to oral prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Monthly pulsed high‐dose dexamethasone compared to oral prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with chronic inflammatory demyelinating polyradiculoneuropathy<br/> <b>Settings:</b> hospital specialist neurological outpatient department<br/> <b>Intervention:</b> monthly pulsed high‐dose dexamethasone<br/> <b>Comparison:</b> oral prednisolone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk or value</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk or value</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Oral prednisolone</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Monthly pulsed high‐dose dexamethasone</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Change in disability after one year</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Remission at 12 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>375 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>416 per 1000</b><br/> (188 to 919) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.11</b> <br/> (CI 0.5 to 2.45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>≥ 1 point improvement on INCAT disability score at 12 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>438 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>542 per 1000</b><br/> (280 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.24</b> <br/> (CI 0.64 to 2.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in impairment: change in MRC sum score at endpoint4</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in the oral prednisolone group was a 1.6 (SD 6.84) point increase</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in MRC sum score with</p> <p>monthly high‐dose dexamethasone was</p> <p><b>2.4 higher</b> (1.9 lower to 6.7 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>3</sup><br/> Low </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in impairment: change in grip strength at endpoint<sup>4</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in the oral prednisolone group was a 13.4 (SD 38.53) kPa increase</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in grip strength with</p> <p>monthly high‐dose dexamethasone was</p> <p><b>5.3 kPa lower</b> (28.43 lower to 17.83 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sleeplessness</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>750 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>330 per 1000</b><br/> (180 to 630) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.44</b> <br/> (CI 0.24 to 0.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>6</sup>Low </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significantly less with</p> <p>monthly high‐dose dexamethasone</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Moon facies</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>688 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>330 per 1000</b><br/> (172 to 639) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.48</b> <br/> (CI 0.25 to 0.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>7</sup><br/> Moderate </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significantly less with</p> <p>monthly high‐dose dexamethasone</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>INCAT</b> : Inflammatory Neuropathy Cause and Treatment; <b>MRC</b> : Medical Research Council; <b>RR:</b> risk ratio; <b>SD</b>: standard deviation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by one, for imprecision. The data are from a single study, which did not achieve planned recruitment, had a small sample size and 95% CI are wide.<br/> <sup>2</sup>Downgraded twice, for imprecision and indirectness. The data are from a single study, which did not achieve planned recruitment, had a small sample size and 95% CI are wide. The INCAT score is not a linear scale.<br/> <sup>3</sup>Downgraded twice, for imprecision and indirectness. The data are from a single study, which did not achieve planned recruitment, had a small sample size and 95% CI are wide; also, the MRC sum is not a linear scale.<br/> <sup>4</sup>The endpoint was 12 months or premature cessation of treatment if after 8 weeks if there had been worsening or no stabilisation, or if there was a relapse back to baseline state, or if there were serious side‐effects due to the drug.<br/> <sup>5</sup>Downgraded by one for imprecision. The data are from a single study, which did not achieve planned recruitment, had a small sample size and 95% CI are wide (imprecision). Grip strength is a linear and direct measure so we did not downgraded a second time.<br/> <sup>6</sup>Downgraded twice, for serious imprecision and indirectness. The data are from a single study, which did not achieve planned recruitment, had a small sample size and 95% CI are wide. Sleeplessness is a subjective outcome caused by many factors.<br/> <sup>7</sup>Downgraded by one for imprecision. The data are from a single study, which did not achieve planned recruitment, had a small sample size and 95% CI are wide. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD002062-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD002062-sec-0030"></div> <section id="CD002062-sec-0031"> <h3 class="title" id="CD002062-sec-0031">Description of the condition</h3> <p>Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is characterised by chronic progressive or relapsing weakness and numbness, especially of the limbs. It affects motor and sensory nerve fibres, but may present with predominantly motor or sensory symptoms. The cerebrospinal fluid (CSF) protein concentration is usually increased. The aetiology of CIDP is presumed to be autoimmune (<a href="./references#CD002062-bbs2-0032" title="HughesRA , AllenD , MakowskaA , GregsonNA . Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. Journal of the Peripheral Nervous System2006;11(1):30‐46. ">Hughes 2006</a>; <a href="./references#CD002062-bbs2-0037" title="MatheyEK , ParkSB , HughesRA , PollardJD , ArmatiPJ , BarnettMH , et al. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. Journal of Neurology, Neurosurgery &amp; Psychiatry2015;86(9):973‐85. ">Mathey 2015</a>; <a href="./references#CD002062-bbs2-0061" title="VallatJM , SommerC , MagyL . Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. Lancet Neurology2010;9(4):402‐12. ">Vallat 2010</a>). Biopsy and autopsy studies of active lesions in the peripheral nerves and spinal roots show oedema, lymphocytic infiltration, and macrophage‐associated segmental demyelination.  </p> <p>The disease is uncommon. It affects males and females of all ages but is more common in the elderly. Estimates of prevalence range from 2 to 9 per 100,000. Prevalences of 2.84 per 100,000 in England (<a href="./references#CD002062-bbs2-0036" title="Mahdi‐RogersM , HughesRA . Epidemiology of chronic inflammatory neuropathies in southeast England. European Journal of Neurology2014;21(1):28‐33. ">Mahdi‐Rogers 2014</a>) and 3.58 per 100,000 in North Italy are typical (<a href="./references#CD002062-bbs2-0012" title="ChiòA , CocitoD , BottacchiE , BuffaC , LeoneM , PlanoF , et al. Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy. Journal of Neurology, Neurosurgery &amp; Psychiatry2007;78(12):1349‐53. ">Chiò 2007</a>). In the English study, 32% of people with CIDP required aid to walk on the prevalence date. </p> <p>Early, large case series described the clinical picture, but did not precisely define the disease (<a href="./references#CD002062-bbs2-0007" title="BarohnRJ , KisselJT , WarmoltsJR , MendellJR . Chronic inflammatory demyelinating polyradiculoneuropathy: Clinical characteristics, course, and recommendations for diagnostic criteria. Archives of Neurology1989;46(8):878‐84. ">Barohn 1989</a>; <a href="./references#CD002062-bbs2-0019" title="DyckPJ , LaisAC , OhtaM , BastronJA , OkazakiH , GrooverRV . Chronic inflammatory polyradiculoneuropathy. Mayo Clinic Proceedings1975;50(11):621‐37. ">Dyck 1975</a>; <a href="./references#CD002062-bbs2-0038" title="McCombePA , PollardJD , McLeodJG . Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain1987;110(Pt 6):1617‐30. ">McCombe 1987</a>; <a href="./references#CD002062-bbs2-0050" title="PrineasJW , McLeodJG . Chronic relapsing polyneuritis. Journal of the Neurological Sciences1976;27(4):427‐58. ">Prineas 1976</a>). Research criteria for the diagnosis were proposed by the Ad Hoc Subcommittee of the American Academy of Neurology Acquired Immunodeficiency Disease (AIDS) Task Force (<a href="./references#CD002062-bbs2-0005" title="American Academy ofNeurology . Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology1991;41(5):617‐8. ">AAN 1991</a>). These required fulfilment of clinical and electrophysiological criteria for a diagnosis of "probable" CIDP, and fulfilment of pathological criteria for a diagnosis of "definite" CIDP in which the progressive phase lasted more than eight weeks. These criteria have been extensively debated. More liberal criteria have been widely adopted, including in this review (<a href="./references#CD002062-bbs2-0062" title="Van denBerghPY , HaddenRD , BoucheP , CornblathDR , HahnA , IllaI , et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society ‐ first revision. European Journal of Neurology2010;17(3):356‐63. ">Van den Bergh 2010</a>). </p> <p>In this review we relied on the authors' diagnosis of CIDP provided that it fulfilled the spirit of the definition of “probable” CIDP proposed by the Ad Hoc Subcommittee (<a href="./references#CD002062-bbs2-0005" title="American Academy ofNeurology . Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology1991;41(5):617‐8. ">AAN 1991</a>). Apart from the neurophysiological evidence of multifocal demyelination, there are no reliable diagnostic tests for CIDP, and the diagnosis is, in part, one of exclusion. Differential diagnoses include hereditary, metabolic, vasculitic, amyloid, paraneoplastic, and paraproteinaemic neuropathies. There is a debate about whether some cases of neuropathy associated with diabetes mellitus, systemic lupus erythematosus, and monoclonal gammopathy are due to CIDP. Because of the uncertainty, we planned to exclude such cases from this review. We also excluded multifocal motor neuropathy with conduction block, which is generally recognised to be a separate entity and does not respond to corticosteroids (<a href="./references#CD002062-bbs2-0064" title="VanSchaikIN , LégerJ‐M , Nobile‐OrazioE , CornblathDR , HaddenRDM , KoskiL , et al. Multifocal motor neuropathy. In: GilhusNE , BarnesMR , BraininM editor(s). European Handbook of Neurological Management. 2nd Edition. Vol. 1, Oxford: Wiley‐Blackwell, 2010:343‐50. [MEDLINE: 13080] ">Van Schaik 2010</a>). </p> </section> <section id="CD002062-sec-0032"> <h3 class="title" id="CD002062-sec-0032">Description of the intervention</h3> <p>Treatments for CIDP are aimed at suppressing an abnormal autoimmune response. Corticosteroids are potent immunosuppressants. Two commonly used corticosteroids are prednisone and prednisolone. Both are usually given as oral tablets. Prednisone is converted into prednisolone in the liver so that the effect of the two drugs is usually the same. Another corticosteroid, called dexamethasone, is more potent and is used in smaller doses. </p> <p><a href="./references#CD002062-bbs2-0006" title="AustinJH . Recurrent polyneuropathies and their corticosteroid treatment. With five‐year observations of a placebo controlled case treated with corticotrophin, cortisone and prednisone. Brain1958;81(2):157. ">Austin 1958</a> reported dramatic improvement with corticosteroids and relapse following withdrawal, even when the withdrawal was done under blind conditions. From then onwards, corticosteroids were extensively used for CIDP, although only one randomised trial comparing corticosteroids with controls was ever done (<a href="./references#CD002062-bbs2-0001" title="DyckPJ , O'BrienPC , OviattKF , DinapoliRP , DaubeJR , BartlesonJD , et al. Prednisone improves chronic inflammatory polyradiculoneuropathy more than no treatment. Annals of Neurology1982;11(2):136‐41. [PUBMED: 7041788] ">Dyck 1982</a>). Subsequently, large retrospective studies on CIDP reported significant improvement after corticosteroids (<a href="./references#CD002062-bbs2-0007" title="BarohnRJ , KisselJT , WarmoltsJR , MendellJR . Chronic inflammatory demyelinating polyradiculoneuropathy: Clinical characteristics, course, and recommendations for diagnostic criteria. Archives of Neurology1989;46(8):878‐84. ">Barohn 1989</a>; <a href="./references#CD002062-bbs2-0014" title="CocitoD , PaolassoI , AntoniniG , BenedettiL , BrianiC , ComiC , et al. A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy. European Journal of Neurology2010;17(2):289‐94. ">Cocito 2010</a>; <a href="./references#CD002062-bbs2-0033" title="KuwabaraS , MisawaS , MoriM , TamuraN , KubotaM , HattoriT . Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases. Journal of Neurology, Neurosurgery &amp; Psychiatry2006;77(1):66‐70. ">Kuwabara 2006</a>; <a href="./references#CD002062-bbs2-0038" title="McCombePA , PollardJD , McLeodJG . Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain1987;110(Pt 6):1617‐30. ">McCombe 1987</a>). The usual regimen has been long‐term oral prednisone or prednisolone, with the dose titrated according to the individual’s response. Alternative regimens of pulsed high‐dose intravenous or oral corticosteroids have been tried, and pulsed high‐dose oral dexamethasone has been compared with standard‐dose oral prednisolone in the <a href="./references#CD002062-bbs2-0002" title="EftimovF , VermeulenM , VanDoornPA , BrusseE , VanSchaikIN , PREDICT . Long‐term remission of CIDP after pulsed dexamethasone or short‐term prednisolone treatment. Neurology2012;78(14):1079‐84. VanSchaikIN , EftimovF , VanDoornPA , BrusseE , Van denBergLH , Van derPolWL , et al. Pulsed high‐dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double‐blind, randomised, controlled trial. Lancet Neurology2010;9(3):245‐53. [PUBMED: 20133204] ">PREDICT 2010</a> trial. </p> <p>Although corticosteroids were the first treatment to be used in CIDP, plasma exchange and intravenous immunoglobulin (IVIg) have since been used in randomised controlled trials (RCTs) and shown in Cochrane reviews to be efficacious short‐term treatments (<a href="./references#CD002062-bbs2-0024" title="EftimovF , WinerJB , VermeulenM , DeHaanR , VanSchaikIN . Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD001797.pub3] ">Eftimov 2013</a>; <a href="./references#CD002062-bbs2-0040" title="MehndirattaMM , HughesRA , PritchardJ . Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database of Systematic Reviews2015, Issue 8. [DOI: 10.1002/14651858.CD003906.pub4] ">Mehndiratta 2015</a>). Limited studies have suggested that plasma exchange is not significantly different from IVIg in efficacy (<a href="./references#CD002062-bbs2-0021" title="DyckPJ , LitchyWJ , KratzKM , SuarezGA , LowPA , PinedaAA , et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Annals of Neurology1994;36(6):838‐45. ">Dyck 1994</a>), and that IVIg is not significantly different from oral prednisolone (<a href="./references#CD002062-bbs2-0031" title="HughesR , BensaS , WillisonH , Van denBerghP , ComiG , IllaI , et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Annals of Neurology2001;50(2):195‐201. ">Hughes 2001</a>). A six‐month trial found no significant difference in the outcomes between IVIg and intravenous methylprednisolone (<a href="./references#CD002062-bbs2-0004" title="Nobile‐OrazioE , CocitoD , JannS , UnciniA , BeghiE , MessinaP , et al. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. Lancet Neurology2012;11(6):493‐502. Nobile‐OrazioE , CocitoD , JannS , UnciniA , MessinaP , AntoniniG , et al. Frequency and time to relapse after discontinuing 6‐month therapy with IVIg or pulsed methylprednisolone in CIDP. Journal of Neurology, Neurosurgery &amp; Psychiatry2015;86(7):729‐34. Nobile‐OrazioE , CocitoD , JannS , UnciniA , MessinaP , AntoniniG , et al. Frequency and time to relapse after therapy discontinuation in CIDP patients treated for six months with IVIG or IV methylprednisolone (IMC study follow‐up). Journal of the Peripheral Nervous System2013;18 Suppl:S80‐1. ">Nobile‐Orazio 2012</a>). These two trials are included in the Cochrane review of IVIg for CIDP (<a href="./references#CD002062-bbs2-0024" title="EftimovF , WinerJB , VermeulenM , DeHaanR , VanSchaikIN . Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD001797.pub3] ">Eftimov 2013</a>). Many different immunosuppressive agents have been tried and reported in case studies and case series; azathioprine, methotrexate, and beta‐interferon have been tested in small RCTs, but none have been shown to be efficacious (<a href="./references#CD002062-bbs2-0035" title="Mahdi‐RogersM , SwanAV , VanDoornPA , HughesRA . Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD003280.pub4] ">Mahdi‐Rogers 2010</a>). </p> </section> <section id="CD002062-sec-0033"> <h3 class="title" id="CD002062-sec-0033">How the intervention might work</h3> <p>Corticosteroids are widely used in medicine as anti‐inflammatory agents. They are lipid soluble so that they can easily cross the cell membrane and engage the glucocorticoid receptor in the cytoplasm. The corticosteroid‐receptor complex translocates to the nucleus and modifies the transcription of genes, resulting in inhibition of inflammatory mediator release, increase of anti‐inflammatory molecules and reduction of circulating T‐lymphocytes. In high doses there are also more rapidly acting non‐genomic effects on membrane lipids and cytoplasmic proteins which also have an anti‐inflammatory effect (<a href="./references#CD002062-bbs2-0059" title="StrehlC , ButtgereitF . Optimized glucocorticoid therapy: teaching old drugs new tricks. Molecular and Cellular Endocrinology2013;380(1‐2):32‐40. ">Strehl 2013</a>). </p> </section> <section id="CD002062-sec-0034"> <h3 class="title" id="CD002062-sec-0034">Why it is important to do this review</h3> <p>In view of the lack of evidence of efficacy for cytotoxic and immunomodulatory drugs in CIDP, and the expense and inconvenience of IVIg and plasma exchange, it is important to know the strength of the evidence for corticosteroids, which are commonly recommended as first line treatment. This is an update of a review first published in 2001; the previous update was in 2015. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD002062-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD002062-sec-0035"></div> <p>To assess the effects of corticosteroid treatment for CIDP compared to placebo or no treatment, and to compare the efficacy of different corticosteroid regimens. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD002062-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD002062-sec-0036"></div> <section id="CD002062-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD002062-sec-0038"> <h4 class="title">Types of studies</h4> <p>We searched for all RCTs or quasi‐RCTs involving any form of corticosteroid or adrenocorticotrophic hormone for the treatment of CIDP. Quasi‐RCTs are studies in which treatment allocation is organised in a way which is intended to have the effect of randomisation but which might nevertheless be biased (e.g. alternate allocation). </p> </section> <section id="CD002062-sec-0039"> <h4 class="title">Types of participants</h4> <p>We included trials in which the study authors had diagnosed participants as having CIDP according to the probable or definite criteria of the European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS) (<a href="./references#CD002062-bbs2-0062" title="Van denBerghPY , HaddenRD , BoucheP , CornblathDR , HahnA , IllaI , et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society ‐ first revision. European Journal of Neurology2010;17(3):356‐63. ">Van den Bergh 2010</a>). Participants must have had symptoms and signs of peripheral neuropathy characterised by progressive or relapsing motor and sensory dysfunction of more than one limb, and of more than eight weeks' duration. An electrophysiological diagnosis of demyelinating neuropathy based on reduced nerve conduction velocities or partial conduction blocks must have confirmed the clinical diagnosis. The diagnosis might have been confirmed by finding a raised cerebrospinal fluid (CSF) protein or the demonstration of inflammation and macrophage‐associated demyelination in a nerve biopsy, but we did not consider these mandatory. We excluded participants with clinical features or investigations suggestive of hereditary neuropathy, relevant systemic disease, or paraproteinaemia. </p> </section> <section id="CD002062-sec-0040"> <h4 class="title">Types of interventions</h4> <p>We included treatment with any form of corticosteroid or adrenocorticotrophic hormone compared with either placebo or no treatment, and comparisons of different corticosteroid regimens. We did not include comparisons of corticosteroids with other treatments. </p> </section> <section id="CD002062-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD002062-sec-0042"> <h5 class="title">Primary outcomes</h5> <p>Change in disability, measured by a validated scale such as the Inflammatory Neuropathy Cause and Treatment (INCAT) disability scale (<a href="./references#CD002062-bbs2-0031" title="HughesR , BensaS , WillisonH , Van denBerghP , ComiG , IllaI , et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Annals of Neurology2001;50(2):195‐201. ">Hughes 2001</a>), Overall Disability Status Scale (ODSS) (<a href="./references#CD002062-bbs2-0042" title="MerkiesIS , SchmitzPI , Van derMechéFG , SamijnJP , VanDoornPA . Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. Journal of Neurology, Neurosurgery &amp; Psychiatry2002;72(5):596‐601. ">Merkies 2002</a>), Overall Neuropathy Limitations Scale (ONLS) (<a href="./references#CD002062-bbs2-0028" title="GrahamRC , HughesRA . A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. Journal of Neurology, Neurosurgery &amp; Psychiatry2006;77(8):973‐6. ">Graham 2006</a>) or Rasch‐built Overall Disability Scale (R‐ODS) (<a href="./references#CD002062-bbs2-0063" title="VanNesSI , VanhoutteEK , VanDoornPA , HermansM , BakkersM , KuitwaardK , et al. Rasch‐built Overall Disability Scale (R‐ODS) for immune‐mediated peripheral neuropathies. Neurology2011;76(4):337‐45. ">Van Nes 2011</a>) after one year. </p> </section> <section id="CD002062-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD002062-list-0001"> <li> <p>Change in impairment after three months and one year, measured by a validated scale such as the Mayo Neuropathy Impairment Scale (NIS) (<a href="./references#CD002062-bbs2-0020" title="DyckPJ , ShermanWR , HallcherLM , ServiceFJ , O'BrienPC , GrinaLA , et al. Human diabetic endoneurial sorbitol, fructose and myo‐inositol related to sural nerve morphometry. Annals of Neurology1980;8(6):590‐6. ">Dyck 1980</a>), Medical Research Council (MRC) Sum Score (<a href="./references#CD002062-bbs2-0043" title="MerkiesIS , LauriaG . 131st ENMC international workshop: selection of outcome measures for peripheral neuropathy clinical trials 10‐12 December 2004, Naarden, The Netherlands. Neuromuscular Disorders2006;16(2):149‐56. ">Merkies 2006</a>), or grip strength (<a href="./references#CD002062-bbs2-0041" title="MerkiesISJ , SchmitzPIM , SamijnJPA , Van derMechéFGA , ToykaKV , VanDoornPA , et al. Assessing grip strength in healthy individuals and patients with immune‐mediated polyneuropathies. Muscle &amp; Nerve2000;23(9):1393‐401. ">Merkies 2000</a>). </p> </li> <li> <p>Side effects of corticosteroids for as long as data allowed. We intended to record all reported side effects, including development of diabetes mellitus, infection requiring the use of antibiotics, hypertension requiring treatment, hip fracture, peptic ulcer, gastrointestinal haemorrhage, depression, psychosis, cataract, and change in appearance (hair loss, facial hirsutism, weight loss, and weight redistribution). </p> </li> </ol> </p> </section> </section> </section> <section id="CD002062-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD002062-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We modified the search strategy for this update to make it more specific. On 8 November 2016, we searched the Cochrane Neuromuscular Specialised Register, Cochrane Central Register of Controlled Trials (CENTRAL, 8 November 2016 in the <i>Cochrane Register of Studies Online</i>), MEDLINE (January 1966 to November 2016), and Embase (January 1980 to November 2016). See <a href="./appendices#CD002062-sec-0077">Appendix 1</a> (Cochrane Neuromuscular Specialised Register), <a href="./appendices#CD002062-sec-0078">Appendix 2</a> (CENTRAL), <a href="./appendices#CD002062-sec-0079">Appendix 3</a> (MEDLINE), and <a href="./appendices#CD002062-sec-0080">Appendix 4</a> (Embase). </p> </section> <section id="CD002062-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We also consulted disease experts and on 28 November 2016 searched US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>), World Health Organization International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/en/" target="_blank">www.who.int/ictrp/en/</a>) (<a href="./appendices#CD002062-sec-0081">Appendix 5</a>), and references in reviews and case series of CIDP. </p> </section> </section> <section id="CD002062-sec-0047"> <h3 class="title" id="CD002062-sec-0047">Data collection and analysis</h3> <p>Two review authors (RACH and MMM) checked titles and abstracts identified in the literature searches. We obtained the full text of potentially includable studies for independent assessment by both authors. Two authors (RACH and MMM) assessed risk of bias according to the method proposed in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD002062-bbs2-0030" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <p>We reported dichotomous data as a risk ratio (RR) and continuous data as a mean difference (MD), each with corresponding 95% confidence intervals (CI). </p> <p>If we had found more than one trial investigating a particular intervention, we would have calculated a weighted treatment effect (initially using a fixed‐effect model) across trials using the Cochrane statistical package, Review Manager 5 (<a href="./references#CD002062-bbs2-0054" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD002062-sec-0048" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD002062-sec-0048"></div> <section id="CD002062-sec-0049"> <h3 class="title">Description of studies</h3> <section id="CD002062-sec-0050"> <h4 class="title">Results of the search</h4> <p>We found 30 (3 new) potentially relevant references in the Cochrane Neuromuscular Specialised Register, 29 (8 new) in CENTRAL, 238 (22 new) in MEDLINE and 168 (20 new) in Embase. Of the 55 new references, 7 were already listed in the previous version of the review and the Information Specialist removed 13 by deduplication (<a href="#CD002062-fig-0001">Figure 1</a>). None of the remaining 35 references were RCTs eligible for inclusion. <a href="#CD002062-fig-0002">Figure 2</a> is a PRISMA flow chart illustrating the study selection process. </p> <div class="figure" id="CD002062-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD002062-fig-0001" src="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <div class="figure" id="CD002062-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. Red (‐) = high risk of bias; green (‐) = low risk of bias; yellow (?) (not shown) = unclear risk of bias." data-id="CD002062-fig-0002" src="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. Red (‐) = high risk of bias; green (‐) = low risk of bias; yellow (?) (not shown) = unclear risk of bias. </p> </div> </div> </div> <p>The results of the searches of DARE (one paper), NHSEED (two papers) and HTA database (one paper), produced no additional relevant references and there were none in ClinicalTrials.gov or ICTRP. We found no additional RCTs in the bibliographies of reviews but we have included some additional case series in the <a href="#CD002062-sec-0061">Discussion</a>. </p> </section> <section id="CD002062-sec-0051"> <h4 class="title">Included studies</h4> <p>Only two studies fulfilled the criteria for this review, one comparing corticosteroids with placebo or no treatment (<a href="./references#CD002062-bbs2-0001" title="DyckPJ , O'BrienPC , OviattKF , DinapoliRP , DaubeJR , BartlesonJD , et al. Prednisone improves chronic inflammatory polyradiculoneuropathy more than no treatment. Annals of Neurology1982;11(2):136‐41. [PUBMED: 7041788] ">Dyck 1982</a>), and another comparing two different corticosteroid regimens (<a href="./references#CD002062-bbs2-0002" title="EftimovF , VermeulenM , VanDoornPA , BrusseE , VanSchaikIN , PREDICT . Long‐term remission of CIDP after pulsed dexamethasone or short‐term prednisolone treatment. Neurology2012;78(14):1079‐84. VanSchaikIN , EftimovF , VanDoornPA , BrusseE , Van denBergLH , Van derPolWL , et al. Pulsed high‐dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double‐blind, randomised, controlled trial. Lancet Neurology2010;9(3):245‐53. [PUBMED: 20133204] ">PREDICT 2010</a>). An additional trial comparing intravenous methylprednisolone with intravenous immunoglobulin (<a href="./references#CD002062-bbs2-0004" title="Nobile‐OrazioE , CocitoD , JannS , UnciniA , BeghiE , MessinaP , et al. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. Lancet Neurology2012;11(6):493‐502. Nobile‐OrazioE , CocitoD , JannS , UnciniA , MessinaP , AntoniniG , et al. Frequency and time to relapse after discontinuing 6‐month therapy with IVIg or pulsed methylprednisolone in CIDP. Journal of Neurology, Neurosurgery &amp; Psychiatry2015;86(7):729‐34. Nobile‐OrazioE , CocitoD , JannS , UnciniA , MessinaP , AntoniniG , et al. Frequency and time to relapse after therapy discontinuation in CIDP patients treated for six months with IVIG or IV methylprednisolone (IMC study follow‐up). Journal of the Peripheral Nervous System2013;18 Suppl:S80‐1. ">Nobile‐Orazio 2012</a>) did not fulfil the inclusion criteria for this review and has been considered in another Cochrane Review (<a href="./references#CD002062-bbs2-0024" title="EftimovF , WinerJB , VermeulenM , DeHaanR , VanSchaikIN . Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD001797.pub3] ">Eftimov 2013</a>). </p> <section id="CD002062-sec-0052"> <h5 class="title">Comparison of oral prednisone with no treatment</h5> <p><a href="./references#CD002062-bbs2-0001" title="DyckPJ , O'BrienPC , OviattKF , DinapoliRP , DaubeJR , BartlesonJD , et al. Prednisone improves chronic inflammatory polyradiculoneuropathy more than no treatment. Annals of Neurology1982;11(2):136‐41. [PUBMED: 7041788] ">Dyck 1982</a> compared corticosteroids to no treatment, but did not compare corticosteroids to placebo. The trial recruited 40 participants over 58 months, and assigned them alternately to prednisone or no treatment. Five participants were removed (three in the treated group, and two from the control group) because of misdiagnosis. A further seven (five in the treatment group, and two in the control group) did not complete the study. Of the five assigned to prednisone and excluded, one died from cardiac arrhythmia, possibly related to hyperglycaemia, three had their prednisone dosage altered from that allowed by the schedule, and one remained dependent on a respirator and did not complete follow‐up. Two participants in the control group worsened and were started on prednisone by their referring physicians because of deterioration in their neurological status. Of the 28 participants completing the trial, 14 participants belonged to each group (see <a href="./references#CD002062-sec-0091" title="">Characteristics of included studies</a><i>)</i>. The treatment group started on prednisone at a dosage of 120 mg every other day, tapered to 0 mg by the end of 12 weeks. The participants in the two groups were well matched for age, sex, initial neurology disability score, muscle strength, cutaneous sensation, nerve conduction values, and CSF protein. The prednisone group included seven participants with a progressive course and seven with a recurrent course. The untreated group comprised 12 participants with a progressive course and two with a recurrent course. </p> </section> <section id="CD002062-sec-0053"> <h5 class="title">Comparison of high‐dose monthly oral dexamethasone with standard‐dose daily oral prednisolone</h5> <p>One parallel group, double‐blind RCT with 41 participants compared two different oral corticosteroid regimens (<a href="./references#CD002062-bbs2-0002" title="EftimovF , VermeulenM , VanDoornPA , BrusseE , VanSchaikIN , PREDICT . Long‐term remission of CIDP after pulsed dexamethasone or short‐term prednisolone treatment. Neurology2012;78(14):1079‐84. VanSchaikIN , EftimovF , VanDoornPA , BrusseE , Van denBergLH , Van derPolWL , et al. Pulsed high‐dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double‐blind, randomised, controlled trial. Lancet Neurology2010;9(3):245‐53. [PUBMED: 20133204] ">PREDICT 2010</a>) (see <a href="./references#CD002062-sec-0091" title="">Characteristics of included studies</a>). One group received six cycles of dexamethasone 40 mg daily for four days, followed by placebo for 24 days. The other group received prednisolone for 32 weeks, starting with 60 mg daily for five weeks and then gradually tapering to zero by the 32nd week. </p> </section> </section> </section> <section id="CD002062-sec-0054"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD002062-sec-0055"> <h4 class="title">Comparison of oral prednisone with no treatment</h4> <p>In <a href="./references#CD002062-bbs2-0001" title="DyckPJ , O'BrienPC , OviattKF , DinapoliRP , DaubeJR , BartlesonJD , et al. Prednisone improves chronic inflammatory polyradiculoneuropathy more than no treatment. Annals of Neurology1982;11(2):136‐41. [PUBMED: 7041788] ">Dyck 1982</a>, treatment allocation was randomised for the first person in each pair of participants, but the second person received the alternative treatment, which was supportive care without steroids. There was no placebo, so randomisation was not concealed from the participant. The report does not state whether allocation was concealed from the investigator, or whether follow‐up assessments were blinded. The numbers of participants randomised, withdrawn, and not completing treatment were available and the analysis took into account baseline characteristics. In view of the lack of allocation concealment and blinding, we considered this trial to have a high risk of bias (See <a href="./references#CD002062-sec-0091" title="">Characteristics of included studies</a>; <a href="#CD002062-fig-0002">Figure 2</a>). </p> </section> <section id="CD002062-sec-0056"> <h4 class="title">Comparison of high‐dose monthly oral dexamethasone with standard‐dose daily oral prednisolone</h4> <p><a href="./references#CD002062-bbs2-0002" title="EftimovF , VermeulenM , VanDoornPA , BrusseE , VanSchaikIN , PREDICT . Long‐term remission of CIDP after pulsed dexamethasone or short‐term prednisolone treatment. Neurology2012;78(14):1079‐84. VanSchaikIN , EftimovF , VanDoornPA , BrusseE , Van denBergLH , Van derPolWL , et al. Pulsed high‐dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double‐blind, randomised, controlled trial. Lancet Neurology2010;9(3):245‐53. [PUBMED: 20133204] ">PREDICT 2010</a> had a low risk of bias since randomisation was performed, allocation was carefully concealed, and trial medication was identical in appearance in both groups (<a href="./references#CD002062-sec-0091" title="">Characteristics of included studies</a>; <a href="#CD002062-fig-0002">Figure 2</a>).   </p> </section> </section> <section id="CD002062-sec-0057"> <h3 class="title" id="CD002062-sec-0057">Effects of interventions</h3> <p>See: <a href="./full#CD002062-tbl-0001"><b>Summary of findings for the main comparison</b> Prednisone for chronic inflammatory demyelinating polyradiculoneuropathy</a>; <a href="./full#CD002062-tbl-0002"><b>Summary of findings 2</b> Monthly pulsed high‐dose dexamethasone compared to oral prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy</a> </p> <section id="CD002062-sec-0058"> <h4 class="title">Comparison of oral prednisone with no treatment</h4> <p>Data for our primary outcome measure, change in disability, were not available for this comparison, but the trial provided data for our secondary outcome measure, change in impairment after three months. In their own analysis, the authors of <a href="./references#CD002062-bbs2-0001" title="DyckPJ , O'BrienPC , OviattKF , DinapoliRP , DaubeJR , BartlesonJD , et al. Prednisone improves chronic inflammatory polyradiculoneuropathy more than no treatment. Annals of Neurology1982;11(2):136‐41. [PUBMED: 7041788] ">Dyck 1982</a> omitted seven participants who breached their protocol, and reported the results for the remainder. The median score at baseline was 74 NIS points in both groups, with the lowest values being 28, and the highest 137. A healthy person would score zero, with higher values indicating more impairment, with the worst possible score being 280 (the scale is non‐linear). After 12 weeks, there was a median deterioration in the NIS score of 1.5 points in the untreated group and an improvement in the prednisone group of 10 points, giving a significant result (P = 0.016) (data directly from paper). We were concerned that omission of the seven participants biased the results in favour of prednisone treatment. We repeated their calculations, including the participants who breached protocol and had been excluded, so as to perform a true intention‐to‐treat (ITT) analysis. When we imputed the worst value for each group for the missing values, the results still favoured prednisone treatment (median increase (worsening) of two points in the control, and decrease (improvement) of five points in the prednisone group), but the difference was not statistically significant. We also calculated the mean improvement in impairment and 95% CI when the seven withdrawn participants were excluded, leaving 28 participants (MD 17.14, 95% CI ‐4.39 to 38.67), or when they were included with the assumption that they had not improved (MD 11.60, 95% CI ‐9.39 to 32.58) (<a href="./references#CD002062-fig-0003" title="">Analysis 1.1</a>; <a href="./references#CD002062-fig-0004" title="">Analysis 1.2</a>; <a href="./full#CD002062-tbl-0001">summary of findings Table for the main comparison</a>). Although both effect estimates suggested that prednisone may be of clinical benefit, we consider the effects uncertain because vulnerable to the effects of missing data, other risks of bias, and imprecision, with wide CI that encompassed benefit and potential harm; the evidence was very low quality. </p> <p>An alternative method of looking at this outcome, albeit not one which we had stipulated in our protocol, was to compare the proportions of participants who had improved, stayed the same, or worsened after 12 weeks. When this analysis was done omitting the seven participants who breached protocol (i.e. in 28 participants), five participants showed spontaneous improvement, one remained the same, and eight worsened in the control group. On the other hand, in the treatment group, 12 participants improved from their initial impairment score, while two worsened. These proportions favoured prednisone (RR 2.40, 95% CI 1.15 to 5.00; very low‐quality evidence; <a href="./references#CD002062-fig-0005" title="">Analysis 1.3</a>; <a href="./full#CD002062-tbl-0001">summary of findings Table for the main comparison</a>). When we repeated this analysis on all 35 participants, categorising the seven who were withdrawn as not having improved, the result still favoured prednisone, but the effect was slightly smaller and the lower CI encompassed the possibility of no effect; the RR for improvement was 2.02 (95% CI 0.90 to 4.52; very low‐quality evidence; <a href="./references#CD002062-fig-0006" title="">Analysis 1.4</a>; <a href="./full#CD002062-tbl-0001">summary of findings Table for the main comparison</a>). Other measures of impairment reported by the investigators in the 28 participants who were followed up: touch‐pressure threshold on the hand (P = 0.017) and grip strength (P = 0.046), showed significantly more improvement in the prednisone‐treated group than the untreated group. These measures were not available for those who were withdrawn and so an ITT analysis was not possible. </p> <p>The only reported side effect related to treatment was the occurrence of hyperglycaemia in one participant treated with prednisone who was withdrawn. </p> <section id="CD002062-sec-0059"> <h5 class="title">Outcomes reported but not included in our predefined outcome measures</h5> <p>Data were also available for electrophysiological outcome measures. Amplitudes, conduction velocities, and latencies of motor fibres of ulnar, median, and peroneal nerves as well as amplitudes and distal latencies of digital nerve action potentials of the median and ulnar nerves were obtained at onset and at three months. The following variables showed significant improvement in the prednisone compared to the control group: median (P = 0.029) and peroneal (P = 0.056) motor nerve conduction velocity and median nerve compound muscle action potential amplitude (P = 0.056). The data on these parameters were not available for those participants who did not complete the protocol. </p> </section> </section> <section id="CD002062-sec-0060"> <h4 class="title">Comparison of high‐dose monthly oral dexamethasone with standard‐dose daily oral prednisolone</h4> <p><a href="./references#CD002062-bbs2-0002" title="EftimovF , VermeulenM , VanDoornPA , BrusseE , VanSchaikIN , PREDICT . Long‐term remission of CIDP after pulsed dexamethasone or short‐term prednisolone treatment. Neurology2012;78(14):1079‐84. VanSchaikIN , EftimovF , VanDoornPA , BrusseE , Van denBergLH , Van derPolWL , et al. Pulsed high‐dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double‐blind, randomised, controlled trial. Lancet Neurology2010;9(3):245‐53. [PUBMED: 20133204] ">PREDICT 2010</a> did not report the outcomes preselected for this review, but did report meaningful outcomes. The primary outcome defined by the trial authors was reaching and remaining in remission without treatment at 12 months. Remission was defined as a minimum of three points improvement on the RMI and minimum of one point improvement in the INCAT disability scale. If a participant did not show improvement or disease stabilisation compared with baseline at eight weeks, or relapsed or had serious side effects, trial treatment was stopped and this was considered a treatment failure. </p> <p>Forty‐one people were randomly assigned. After one day of trial assignment, one person, who had not by then received any treatment, withdrew because of rapid progression in disease and change in diagnosis. Twenty‐four participants were assigned to dexamethasone and 16 to prednisolone. The dexamethasone and prednisolone groups were well matched at baseline. Eighteen men and six women were randomised to dexamethasone and 10 men and six women to prednisolone. The mean (range) age was 59.9 (25.8 to 80.2) years in the dexamethasone group and 60.8 (25.3 to 87.7) years in the prednisolone group. The mean (interquartile range) disease duration was 13.5 (5.3 to 28.5) months in the dexamethasone group and 8.5 (6.0 to 15.0) months in the prednisolone group. </p> <p>In the analysis of the trial authors' primary outcome, 10 out of 24 in the dexamethasone group and six out of 16 in the prednisolone group achieved remission at the end of one year, a difference slightly in favour of dexamethasone, but with wide CI that included the possibility of clinically relevant differences in either direction (RR 1.11; 95% CI 0.50 to 2.45; moderate‐quality evidence; <a href="./references#CD002062-fig-0007" title="">Analysis 2.1</a>; <a href="./full#CD002062-tbl-0002">summary of findings Table 2</a>). Seven of 24 participants in the dexamethasone and eight of 16 participants in the prednisolone group deteriorated. There were no significant differences between the groups in any of the secondary outcomes measured by the authors, including change at endpoint in MRC sum score (<a href="./references#CD002062-fig-0009" title="">Analysis 2.3</a>; low‐quality evidence), grip strength (<a href="./references#CD002062-fig-0010" title="">Analysis 2.4</a>; moderate‐quality evidence), disability scale, INCAT sensory sum score (low‐quality evidence), or Short Form‐36 Health Survey quality of life scores. The endpoint was 12 months or premature cessation of treatment if after eight weeks if there had been worsening or no stabilisation, or if there was a relapse back to baseline state, or if there were serious side‐effects due to the drug. There was a suggestion that improvement was faster in the dexamethasone treated group; median time to remission was 20 weeks (95% CI 12.4 to 27.6) in the dexamethasone group in comparison to 39 weeks (95% CI 29.9 to 48.1) in the prednisolone group (P = 0.057). Median time to improvement by one point in the INCAT disability scale was 17 weeks (95% CI 13.8 to 20.2) in the dexamethasone group and 39 weeks (29.9 to 48.1) in the prednisolone group (P = 0.036). </p> <p>Side effects, including diabetes mellitus, hypertension, and osteopenia, were comparably common in both groups, with the exception of sleeplessness and cushingoid facies, which were more common in the daily prednisolone group (RR 0.44, 0.24 to 0.84 and RR 0.50, 0.21 to 1.17, respectively; low‐ and moderate‐quality evidence) (<a href="./references#CD002062-fig-0011" title="">Analysis 2.5</a>; <a href="./references#CD002062-fig-0012" title="">Analysis 2.6</a>; <a href="./full#CD002062-tbl-0002">summary of findings Table 2</a>). Severe weight gain (&gt; 3 kg) was more common with daily prednisolone than with dexamathasone (RR 0.11, 95% CI 0.01 to 0.84) but weight gain of 1 kg to 3 kg was not, although this result was somewhat imprecise (RR 0.96, 95% CI 0.55 to 1.70) (<a href="./references#CD002062-fig-0013" title="">Analysis 2.7</a>; <a href="./references#CD002062-fig-0014" title="">Analysis 2.8</a>). One participant in the dexamethasone group developed acute glaucoma after one cycle and stopped treatment. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD002062-sec-0061" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD002062-sec-0061"></div> <section id="CD002062-sec-0062"> <h3 class="title" id="CD002062-sec-0062">Comparison of corticosteroids with no treatment</h3> <section id="CD002062-sec-0063"> <h4 class="title">Summary of the main results and quality of the evidence</h4> <p>The <a href="./references#CD002062-bbs2-0001" title="DyckPJ , O'BrienPC , OviattKF , DinapoliRP , DaubeJR , BartlesonJD , et al. Prednisone improves chronic inflammatory polyradiculoneuropathy more than no treatment. Annals of Neurology1982;11(2):136‐41. [PUBMED: 7041788] ">Dyck 1982</a> trial comparing prednisone for 12 weeks with no treatment was a pioneering study in the field of inflammatory neuropathy. By modern standards the trial had a high risk of bias because of failure to conceal allocation, absence of blinding, and lack of ITT analysis. Additionally, the sample size was small, the outcome measures non‐linear and compound, and the result imprecise. The trial authors concluded that corticosteroids significantly reduced impairment and improved measures of nerve conduction. There was no information concerning disability, our preferred primary outcome measure. When we imputed pessimistic values for the participants who were withdrawn and re‐analysed, the results for one of our secondary outcome measures, improvement in impairment 12 weeks after randomisation, favoured corticosteroids, but the quality of evidence was very low (<a href="./full#CD002062-tbl-0001">summary of findings Table for the main comparison</a>). The interpretation of the results of the trial is critically dependent on how the withdrawn participants are analysed. One withdrawn prednisone participant died and another remained ventilated, which favours no prednisone. Two withdrawn control participants worsened and then improved on prednisone, which favours prednisone. In the study authors' own analysis, excluding the seven participants who breached protocol, there was significant improvement in measures of sensory threshold, grip strength and nerve conduction. The absence of a true ITT analysis seriously weakens the strength of the evidence that corticosteroids are beneficial. </p> </section> <section id="CD002062-sec-0064"> <h4 class="title">Overall completeness and applicability of the evidence</h4> <p>There have been no trials comparing corticosteroids with placebo in CIDP. Since there is so little evidence from randomised studies, we also considered large series in which the use of corticosteroids has been reported. In 1958, Austin described recurrent steroid‐responsiveness in two people and reviewed nine others (<a href="./references#CD002062-bbs2-0006" title="AustinJH . Recurrent polyneuropathies and their corticosteroid treatment. With five‐year observations of a placebo controlled case treated with corticotrophin, cortisone and prednisone. Brain1958;81(2):157. ">Austin 1958</a>). In one, Austin demonstrated steroid‐responsiveness through documentation of 20 recurrences over a five‐year period compared with significant progression following oral, intramuscular, and intravenous placebo administration. Others reported benefit from corticosteroids in single cases or small case series (<a href="./references#CD002062-bbs2-0017" title="DeVivoDC , EngelWK . Remarkable recovery of a steroid‐responsive recurrent polyneuropathy. Journal of Neurology, Neurosurgery &amp; Psychiatry1970;33(1):62‐9. ">DeVivo 1970</a>; <a href="./references#CD002062-bbs2-0060" title="ThomasPK , LascellesRG , HallpikeJF , HewerRL . Recurrent and chronic relapsing Guillain‐Barre polyneuritis. Brain1969;92(3):589‐606. ">Thomas 1969</a>). </p> <p><a href="./references#CD002062-bbs2-0016" title="DalakasMC , EngelWK . Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Annals of Neurology1981;9 Suppl:134‐45. ">Dalakas 1981</a> reported 25 people with CIDP treated with corticosteroids alone in an observational study in which "the majority" improved. The study authors emphasised that a lag period, usually of one to four weeks, but occasionally up to five months, occurred from onset of therapy to the first sign of improvement. They recommended high doses of steroids for about one year, then cautious tapering to avoid pharmacorelapses, and long‐term, low, maintenance doses to prevent spontaneous relapses. Beneficial effects of corticosteroids have also been documented in children with CIDP (<a href="./references#CD002062-bbs2-0029" title="HattoriN , IchimuraM , AokiS , NagamatsuM , YasudaT , KumazawaK , et al. Clinicopathological features of chronic inflammatory demyelinating polyradiculoneuropathy in childhood. Journal of the Neurological Sciences1998;154(1):66‐71. ">Hattori 1998</a>; <a href="./references#CD002062-bbs2-0046" title="NevoY , PestronkA , KornbergAJ , ConnollyAM , YeeWC , IqbalI , et al. Childhood chronic inflammatory demyelinating neuropathies. Neurology1996;47(1):98‐102. ">Nevo 1996</a>; <a href="./references#CD002062-bbs2-0057" title="SimmonsZ , WaldJJ , AlbersJW . Chronic inflammatory demyelinating polyradiculoneuropathy in children. II. Long term follow‐up, with comparison to adults. Muscle &amp; Nerve1997;20(12):1569‐75. ">Simmons 1997</a>; <a href="./references#CD002062-bbs2-0058" title="SladkyJT , BrownMJ , BermanPH . Chronic inflammatory demyelinating polyneuropathy of infancy: a corticosteroid responsive disorder. Annals of Neurology1986;20(1):76‐81. ">Sladky 1986</a>). </p> <p><a href="./references#CD002062-bbs2-0038" title="McCombePA , PollardJD , McLeodJG . Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain1987;110(Pt 6):1617‐30. ">McCombe 1987</a> reported a study of 92 cases of all ages. Sixty (65%) participants had a relapsing course and 32 participants (35%) a progressive or monophasic course. Seventy‐six participants were treated with corticosteroids. Forty‐nine participants (65%) made a good recovery and were independent. Similarly, <a href="./references#CD002062-bbs2-0007" title="BarohnRJ , KisselJT , WarmoltsJR , MendellJR . Chronic inflammatory demyelinating polyradiculoneuropathy: Clinical characteristics, course, and recommendations for diagnostic criteria. Archives of Neurology1989;46(8):878‐84. ">Barohn 1989</a> studied 60 people aged 10 to 77 years. A consistent approach to treatment was used over the decade of observation. Participants were started on a regimen of 100 mg of prednisone daily for two to four weeks and then switched to prednisone 100 mg in a single dose on alternate days. This regimen was continued until clinical improvement plateaued. If the participant's response was poor or a relapse occurred, either azathioprine or plasma exchange was added to the treatment. Fifty‐six (94.9%) of 59 treated participants showed initial improvement with immunosuppressive treatment. The mean (standard deviation (SD)) time for improvement was 1.9 (3.6) months. The mean time to reach a clinical plateau was 6.6 (5.4) months. In an abstract, <a href="./references#CD002062-bbs2-0034" title="MachkhasH , HaratiY . Pulse intravenous methylprednisolone (IVMP) in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Neurology1997; Vol. 48, issue 3 Suppl:A87‐8. ">Machkhas 1997</a> reported benefit from pulsed intravenous methylprednisolone 1000 mg daily for five days and then 1000 mg daily every one to four weeks in five people with CIDP. Side effects were not reported. <a href="./references#CD002062-bbs2-0056" title="SabatelliM , MadiaF , MignognaT , LippiG , QuarantaL , TonaliP . Pure motor chronic inflammatory demyelinating polyneuropathy. Journal of Neurology2001;248(9):772‐7. ">Sabatelli 2001</a> reported that four people with pure motor CIDP did not respond to prednisolone but all four responded to IVIg. Particularly helpful is the detailed, albeit retrospective, Italian national study which included 136 people with CIDP treated with corticosteroids as first line therapy, of whom 51% responded with a one or more point improvement in the Rankin score and 19 of whom (12.5%) had side effects (five people with diabetes mellitus, four with hypertension, three with osteoporosis, three with duodenal ulcer, two with psychosis, and one with obesity) (<a href="./references#CD002062-bbs2-0014" title="CocitoD , PaolassoI , AntoniniG , BenedettiL , BrianiC , ComiC , et al. A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy. European Journal of Neurology2010;17(2):289‐94. ">Cocito 2010</a>). Fourteen participants who had previously been treated with IVIg were switched to corticosteroids, and six (43%) responded. This large systematic national survey suggests that corticosteroids induce at least short‐term improvement in about half of people with CIDP, less than the 65% or more suggested by smaller case series studies from single centres. It also documents the improvement of some people on corticosteroids after switching from IVIg, which has been noted before (<a href="./references#CD002062-bbs2-0048" title="PedersenK , PandolfoM , MavroudakisN . Chronic inflammatory demyelinating polyneuropathy in a diabetic patient: deterioration after intravenous immunoglobulins treatment and favorable response to steroid treatment. Acta Neurologica Belgica2007;107(1):14‐7. ">Pedersen 2007</a>). </p> <p>Care must be exercised in starting treatment because some people with CIDP deteriorate, as reported in case series (<a href="./references#CD002062-bbs2-0019" title="DyckPJ , LaisAC , OhtaM , BastronJA , OkazakiH , GrooverRV . Chronic inflammatory polyradiculoneuropathy. Mayo Clinic Proceedings1975;50(11):621‐37. ">Dyck 1975</a>; <a href="./references#CD002062-bbs2-0055" title="RostasyKM , DiepoldK , BuckardJ , BrockmannK , WilkenB , HanefeldF . Progressive muscle weakness after high‐dose steroids in two children with CIDP. Pediatric Neurology2003;29(3):236‐8. ">Rostasy 2003</a>) and <a href="./references#CD002062-bbs2-0002" title="EftimovF , VermeulenM , VanDoornPA , BrusseE , VanSchaikIN , PREDICT . Long‐term remission of CIDP after pulsed dexamethasone or short‐term prednisolone treatment. Neurology2012;78(14):1079‐84. VanSchaikIN , EftimovF , VanDoornPA , BrusseE , Van denBergLH , Van derPolWL , et al. Pulsed high‐dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double‐blind, randomised, controlled trial. Lancet Neurology2010;9(3):245‐53. [PUBMED: 20133204] ">PREDICT 2010</a>. In a post hoc analysis of <a href="./references#CD002062-bbs2-0002" title="EftimovF , VermeulenM , VanDoornPA , BrusseE , VanSchaikIN , PREDICT . Long‐term remission of CIDP after pulsed dexamethasone or short‐term prednisolone treatment. Neurology2012;78(14):1079‐84. VanSchaikIN , EftimovF , VanDoornPA , BrusseE , Van denBergLH , Van derPolWL , et al. Pulsed high‐dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double‐blind, randomised, controlled trial. Lancet Neurology2010;9(3):245‐53. [PUBMED: 20133204] ">PREDICT 2010</a>, seven of 33 participants deteriorated within eight weeks after start of treatment, four patients had received dexamethasone and three had received prednisolone (<a href="./references#CD002062-bbs2-0025" title="EftimovF , LiesdekMH , VerhammeC , VanSchaikIN , on behalf of the PREDICT study group. Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern. BMC Neurology2014;14:72. ">Eftimov 2014</a>). </p> <p>There is no known method for identifying people with CIDP who will deteriorate. Deterioration has been considered more likely in pure motor CIDP (<a href="./references#CD002062-bbs2-0018" title="DonaghyM , MillsKR , BonifaceSJ , SimmonsJ , WrightI , GregsonN , et al. Pure motor demyelinating neuropathy: Deterioration after steroid treatment and improvement with intravenous immunoglobulin. Journal of Neurology, Neurosurgery &amp; Psychiatry1994;57(7):778‐83. ">Donaghy 1994</a>), but also occurs in pure sensory CIDP (<a href="./references#CD002062-bbs2-0013" title="ChroniE , VeltsistaD , GavanoziE , VlachouT , PolychronopoulosP , PapathanasopoulosP . Pure sensory chronic inflammatory polyneuropathy: rapid deterioration after steroid treatment. BMC Neurology2015;15:27. ">Chroni 2015</a>; <a href="./references#CD002062-bbs2-0053" title="RajaballyYA , WongSL . Chronic inflammatory pure sensory polyradiculoneuropathy: a rare CIDP variant with unusual electrophysiology. Journal of Clinical Neuromuscular Disease2012;13(3):149‐52. ">Rajabally 2012</a>). The likelihood of response to steroids in various atypical forms of CIDP is also uncertain. A retrospective review of published accounts of multifocal asymmetric upper limb‐onset CIDP found that 52% of people (14 of 27) treated with steroids improved compared to 74% (31 of 42) of those treated with IVIg. The same review found that people with multifocal asymmetric lower limb‐onset forms were significantly less likely to respond to steroids than IVIg (2 of 8 (25%) versus 14 of 16 (87%)) (<a href="./references#CD002062-bbs2-0052" title="RajaballyYA , ChavadaG . Lewis‐Sumner syndrome of pure upper‐limb onset: diagnostic, prognostic, and therapeutic features. Muscle &amp; Nerve2009;39(2):206‐20. ">Rajabally 2009</a>). According to a retrospective study of seven people with corticosteroid‐responsive disease and seven who were non‐responsive to corticosteroid, corticosteroid response was significantly more likely in those with smaller sensory action potentials and longer upper limb F wave latencies (<a href="./references#CD002062-bbs2-0051" title="RajaballyYA , NarasimhanM , ChavadaG . Electrophysiological predictors of steroid‐responsiveness in chronic inflammatory demyelinating polyneuropathy. Journal of Neurology2008;255(6):936‐8. ">Rajabally 2008</a>). In a retrospective study of 50 people with CIDP (<a href="./references#CD002062-bbs2-0011" title="ChanYC , AllenDC , FialhoD , MillsKR , HughesRA . Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy. Journal of Neurology, Neurosurgery &amp; Psychiatry2006;77(1):114‐6. ">Chan 2006</a>), there was no difference in responsiveness to any immunotherapy (including IVIg, as well as corticosteroids) between 27 people with neurophysiologically definite and 23 people with neurophysiologically probable CIDP, classified according to the INCAT criteria (<a href="./references#CD002062-bbs2-0031" title="HughesR , BensaS , WillisonH , Van denBerghP , ComiG , IllaI , et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Annals of Neurology2001;50(2):195‐201. ">Hughes 2001</a>). Five out of seven people with early deterioration had a focal distribution pattern of demyelination, compared to only five out of 26 people without early deterioration (P = 0.02) (<a href="./references#CD002062-bbs2-0025" title="EftimovF , LiesdekMH , VerhammeC , VanSchaikIN , on behalf of the PREDICT study group. Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern. BMC Neurology2014;14:72. ">Eftimov 2014</a>). This observation suggests that a focal pattern of demyelination might predict worsening after starting corticosteroids. but this requires confirmation in new prospective studies. The mechanism by which corticosteroids can cause worsening is not known. <a href="./references#CD002062-bbs2-0025" title="EftimovF , LiesdekMH , VerhammeC , VanSchaikIN , on behalf of the PREDICT study group. Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern. BMC Neurology2014;14:72. ">Eftimov 2014</a> speculated that corticosteroids might upregulate the axonal Na+K+ pump, causing hyperpolarisation and conduction block, especially in motor nerve fibres. </p> <p>The issue of side effects is very important in deciding whether to use corticosteroids as the first line treatment for CIDP (<a href="./references#CD002062-bbs2-0010" title="BrombergMB , CarterO . Corticosteroid use in the treatment of neuromuscular disorders: empirical and evidence‐based data. Muscle &amp; Nerve2004;30(1):20‐37. ">Bromberg 2004</a>). Side effects include weight gain, hirsutism, cushingoid or moon facies, susceptibility to overwhelming infection, osteoporosis, hip fracture, hypertension, diabetes mellitus, cataracts, peptic ulcer, gastrointestinal haemorrhage, and psychiatric manifestations (<a href="./references#CD002062-bbs2-0027" title="BernardPS , KeithLP . Adrenocorticotropic hormones; adrenocortical steroids and their synthetic analogues, inhibitors of the synthesis and action of adrenocortical hormones. In: JoelGH , LeeEL editor(s). Goodman and Gilman. The Pharmacological Basis of Therapeutics. 9th Edition. New York: McGraw Hill, 1996:1459‐84. ">Goodman 1996</a>), many of which have been reported in the case series studies described in the discussion above. Many of these effects are not adequately captured in short‐term trials, even those with follow‐up for one year, but are relevant when considering the value of long‐term treatment. </p> <p>Cost is another important consideration. Oral prednisone or prednisolone are cheap to purchase but monitoring for the known side effects incurs costs, and the long‐term costs of serious side effects are substantial. However, even when these are taken into account, corticosteroids are much less expensive than the main alternative, IVIg (<a href="./references#CD002062-bbs2-0008" title="BlackhouseG , GaebelK , XieF , CampbellK , AssasiN , TarrideJE , et al. Cost‐utility of intravenous immunoglobulin (IVIG) compared with corticosteroids for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in Canada. Cost Effectiveness and Resource Allocation2010;8:14. ">Blackhouse 2010</a>; <a href="./references#CD002062-bbs2-0039" title="McCroneP , ChisholmD , KnappM , HughesR , ComiG , DalakasMC , et al. INCAT Study Group. Cost‐utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. European Journal of Neurology2003;10(6):687‐94. ">McCrone 2003</a>). </p> </section> </section> <section id="CD002062-sec-0065"> <h3 class="title" id="CD002062-sec-0065">Comparison of different corticosteroid regimens</h3> <section id="CD002062-sec-0066"> <h4 class="title">Summary of the main results and quality of the evidence</h4> <p>One trial compared a commonly‐used regimen of standard‐dose daily oral prednisolone with monthly, high‐dose, oral dexamethasone (<a href="./references#CD002062-bbs2-0002" title="EftimovF , VermeulenM , VanDoornPA , BrusseE , VanSchaikIN , PREDICT . Long‐term remission of CIDP after pulsed dexamethasone or short‐term prednisolone treatment. Neurology2012;78(14):1079‐84. VanSchaikIN , EftimovF , VanDoornPA , BrusseE , Van denBergLH , Van derPolWL , et al. Pulsed high‐dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double‐blind, randomised, controlled trial. Lancet Neurology2010;9(3):245‐53. [PUBMED: 20133204] ">PREDICT 2010</a>). There was probably little or no difference between regimens in the primary outcome chosen by the trial authors (remission after 12 months). Monthly dexamethasone produced a more rapid one point INCAT improvement than oral prednisolone, which reached statistical significance. Unexpectedly, one‐third of the participants deteriorated, slightly but not significantly more in the daily prednisolone group. Minor side effects were common, and sleeplessness (low‐quality evidence) and cushingoid facies (moderate‐quality evidence) were more common in the prednisolone group. Weight gain of more than 3 kg was more common in the prednisolone group both during treatment and follow‐up periods. The trial had a low risk of bias. The limitations of this evidence, which we judged to be of low to moderate quality for efficacy, are that there was only one trial, the sample size was smaller than intended because of the slow recruitment rate, and some measures were imprecise and also to an extent indirect (<a href="./full#CD002062-tbl-0002">summary of findings Table 2</a>). </p> <p>The trial included an informal follow‐up after a median 4.5 years when data were available from 39 of 40 participants (<a href="./references#CD002062-bbs2-0022" title="EftimovF , VermeulenM , VanDoornPA , BrusseE , VanSchaikIN , The PREDICT study group. Long term follow‐up in CIDP patients treated with 6‐months pulsed dexamethasone or 8‐months prednisolone treatment. 2011 Meeting of the Peripheral Nerve Society June 25–29, 2011, Potomac, Maryland. Journal of the Peripheral Nervous System. 2011, issue 16 Suppl s3:S33‐4. ">Eftimov 2011</a>; <a href="./references#CD002062-bbs2-0023" title="EftimovF , VermeulenM , VanDoornPA , BrusseE , VanSchaikIN , PREDICT . Long‐term remission of CIDP after pulsed dexamethasone or short‐term prednisolone treatment. Neurology2012;78(14):1079‐84. ">Eftimov 2012</a>). Cure (off treatment &gt; five years) or remission (off treatment &gt; five years) occurred in seven out of 24 participants initially treated with pulsed dexamethasone and six out of 16 participants initially treated with prednisolone. Half those in remission after initial treatment relapsed. The median treatment‐free interval was longer, 17.5 months, for pulsed dexamethasone than for conventional dose prednisolone (11 months), which was not a clear difference. Unfortunately, the different treatments received after the end of the one‐year trial confounded these comparisons. Importantly, the diagnosis turned out to be wrong in seven participants, who accounted for more than half of the 12 who did not respond to any treatment. </p> </section> <section id="CD002062-sec-0067"> <h4 class="title">Overall completeness and applicability of the evidence</h4> <p>There have been many case reports, case series studies, and reviews describing widely varying types, doses and routes of corticosteroid usage in CIDP (<a href="./references#CD002062-bbs2-0010" title="BrombergMB , CarterO . Corticosteroid use in the treatment of neuromuscular disorders: empirical and evidence‐based data. Muscle &amp; Nerve2004;30(1):20‐37. ">Bromberg 2004</a>), but no other RCTs. <a href="./references#CD002062-bbs2-0002" title="EftimovF , VermeulenM , VanDoornPA , BrusseE , VanSchaikIN , PREDICT . Long‐term remission of CIDP after pulsed dexamethasone or short‐term prednisolone treatment. Neurology2012;78(14):1079‐84. VanSchaikIN , EftimovF , VanDoornPA , BrusseE , Van denBergLH , Van derPolWL , et al. Pulsed high‐dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double‐blind, randomised, controlled trial. Lancet Neurology2010;9(3):245‐53. [PUBMED: 20133204] ">PREDICT 2010</a> was based on an observational study of six cycles of oral dexamethasone 40 mg daily for four days every four weeks, in which six of ten participants went into remission (<a href="./references#CD002062-bbs2-0044" title="MolenaarDSM , VanDoornPA , VermeulenM . Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: a pilot study. Journal of Neurology, Neurosurgery &amp; Psychiatry1997;62(4):388‐90. ">Molenaar 1997</a>). A retrospective observational study of 39 participants (out of 57 with available records), included 16 participants who received intermittent intravenous methylprednisolone 1000 mg daily for three to five days and then 1000 mg monthly, seven who received IVIg, and 16 people who received oral treatment consisting of either prednisone (in 12) or ciclosporin (in four) (<a href="./references#CD002062-bbs2-0003" title="LopateA , PestronkA , Al‐LoziM . Treatment of chronic inflammatory demyelinating polyneuropathy with high‐dose intermittent intravenous methylprednisolone. Archives of Neurology2005;62(2):249‐54. ">Lopate 2005</a>). After six months, the average improvement in muscle strength was similar in all three groups. Cushingoid appearance and weight gain were more common in those who received oral prednisone. <a href="./references#CD002062-bbs2-0033" title="KuwabaraS , MisawaS , MoriM , TamuraN , KubotaM , HattoriT . Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases. Journal of Neurology, Neurosurgery &amp; Psychiatry2006;77(1):66‐70. ">Kuwabara 2006</a> treated 38 people with CIDP of whom 33 received high‐dose corticosteroids as their first treatment: of these 33, 70% improved by one or more points on the seven‐point GBS disability grade scale by two months. Some people were subsequently treated with IVIg or plasma exchange so that their five‐year status cannot be attributed solely to corticosteroids, but 26% were in complete remission off treatment, 29% were still being treated with corticosteroids, 10% needed aid to walk, and one had died of complications associated with tetraplegia. Side effects were not mentioned. In another retrospective observational study, <a href="./references#CD002062-bbs2-0045" title="MuleySA , KelkarP , ParryGJ . Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids. Archives of Neurology2008;65(11):1460‐4. ">Muley 2008</a> treated 10 people with oral methylprednisolone 500 mg once a week for three months, and the dose was adjusted every three months by 50 mg to 100 mg depending on clinical status. One person stopped treatment after two days because of duodenal ulceration, but six of the remaining nine entered and maintained treatment‐free remission after a mean of 27 (SD 7.04) months. Long‐term skin thinning and cushingoid facies were each reported in three people, and five people developed osteoporosis. </p> <p><a href="./references#CD002062-bbs2-0009" title="BörüUT , ErdoğanH , AlpR , TaşdemirM , YildirimS , BilgiçA , et al. Treatment of chronic inflammatory demyelinating polyneuropathy with high dose intravenous methylprednisolone monthly for five years: 10‐year follow up. Clinical Neurology &amp; Neurosurgery2014;118:89‐93. ">Boru 2014</a> treated 20 people with CIDP with intravenous methylprednisolone 1000 mg/day for 10 days and then 1000 mg monthly for five years. Five people were not followed up, one because of lack of response, another because of nausea and hypertension, and three for reasons unrelated to the study. The remaining 15 all improved compared with baseline by at least one point on the modified Rankin score at the first and fifth year. After five years, treatment was stopped and during a five further years' follow‐up, six participants relapsed. All those relapsing received intravenous methylprednisolone again and three responded. Side‐effects occurred in nearly half the participants, including weight gain in six, but no other participants had to stop treatment. </p> <p>The inclusion criteria for this review did not allow us to consider RCTs comparing corticosteroids with IVIg or other treatments (<a href="./references#CD002062-bbs2-0031" title="HughesR , BensaS , WillisonH , Van denBerghP , ComiG , IllaI , et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Annals of Neurology2001;50(2):195‐201. ">Hughes 2001</a>; <a href="./references#CD002062-bbs2-0004" title="Nobile‐OrazioE , CocitoD , JannS , UnciniA , BeghiE , MessinaP , et al. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. Lancet Neurology2012;11(6):493‐502. Nobile‐OrazioE , CocitoD , JannS , UnciniA , MessinaP , AntoniniG , et al. Frequency and time to relapse after discontinuing 6‐month therapy with IVIg or pulsed methylprednisolone in CIDP. Journal of Neurology, Neurosurgery &amp; Psychiatry2015;86(7):729‐34. Nobile‐OrazioE , CocitoD , JannS , UnciniA , MessinaP , AntoniniG , et al. Frequency and time to relapse after therapy discontinuation in CIDP patients treated for six months with IVIG or IV methylprednisolone (IMC study follow‐up). Journal of the Peripheral Nervous System2013;18 Suppl:S80‐1. ">Nobile‐Orazio 2012</a>). These have been considered in the <a href="./references#CD002062-bbs2-0024" title="EftimovF , WinerJB , VermeulenM , DeHaanR , VanSchaikIN . Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD001797.pub3] ">Eftimov 2013</a> Cochrane review and the <a href="./references#CD002062-bbs2-0047" title="OaklanderAL , LunnMPT , HughesRAC , VanSchaikIN , FrostC , ChalkCH . Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD010369.pub2] ">Oaklander 2017</a> Cochrane overview. </p> </section> </section> <section id="CD002062-sec-0068"> <h3 class="title" id="CD002062-sec-0068">Comparison of corticosteroids with no treatment and comparison of different corticosteroid regimens </h3> <section id="CD002062-sec-0069"> <h4 class="title">Potential biases in the review process</h4> <p>For both the comparisons included in this review, we are confident that we have identified all RCTs comparing corticosteroids with placebo or no treatment and comparing different corticosteroid regimens. However, the exclusion of comparisons with other treatments especially IVIg is a limitation which has been corrected by their inclusion in other reviews (<a href="./references#CD002062-bbs2-0024" title="EftimovF , WinerJB , VermeulenM , DeHaanR , VanSchaikIN . Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD001797.pub3] ">Eftimov 2013</a>; <a href="./references#CD002062-bbs2-0047" title="OaklanderAL , LunnMPT , HughesRAC , VanSchaikIN , FrostC , ChalkCH . Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD010369.pub2] ">Oaklander 2017</a>). We also recognise that it is not possible to identify all the non‐randomised evidence. Our review of published case series may not be complete, and will have been limited by the impossibility of including all treated and untreated people with CIDP. Of concern is that one of the RCTs identified only considered 12 weeks of treatment, and the other only 12 months, whereas in practice, people with CIDP may require treatment for years. Longer RCTs of corticosteroids are unlikely to be done. </p> </section> <section id="CD002062-sec-0070"> <h4 class="title">Agreements and disagreements with other studies or reviews</h4> <p>There have been no other systematic reviews. The conclusions of this review are in line with the assessment of the evidence by an international expert panel (<a href="./references#CD002062-bbs2-0062" title="Van denBerghPY , HaddenRD , BoucheP , CornblathDR , HahnA , IllaI , et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society ‐ first revision. European Journal of Neurology2010;17(3):356‐63. ">Van den Bergh 2010</a>). A more recent non‐systematic review including the comparison of corticosteroids with IVIg supports the use of pulsed high‐dose corticosteroids rather than IVIg as the first treatment choice in people with non‐motor‐dominant CIDP who are not extremely disabled (<a href="./references#CD002062-bbs2-0049" title="PressR , HiewFL , RajaballyYA . Steroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice. Acta Neurologica Scandinavica2016;133(4):228‐38. ">Press 2016</a>). Two other Cochrane reviews consider the comparison of corticosteroids with IVIg (<a href="./references#CD002062-bbs2-0024" title="EftimovF , WinerJB , VermeulenM , DeHaanR , VanSchaikIN . Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD001797.pub3] ">Eftimov 2013</a>; <a href="./references#CD002062-bbs2-0047" title="OaklanderAL , LunnMPT , HughesRAC , VanSchaikIN , FrostC , ChalkCH . Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD010369.pub2] ">Oaklander 2017</a>). </p> </section> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD002062-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/urn:x-wiley:14651858:media:CD002062:CD002062-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_t/tCD002062-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD002062-fig-0001" src="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/full#CD002062-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002062-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/urn:x-wiley:14651858:media:CD002062:CD002062-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_t/tCD002062-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. Red (‐) = high risk of bias; green (‐) = low risk of bias; yellow (?) (not shown) = unclear risk of bias." data-id="CD002062-fig-0002" src="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. Red (‐) = high risk of bias; green (‐) = low risk of bias; yellow (?) (not shown) = unclear risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/full#CD002062-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002062-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/urn:x-wiley:14651858:media:CD002062:CD002062-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_t/tCD002062-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus control, Outcome 1 Improvement in impairment after 12 weeks excluding those who did not complete the study." data-id="CD002062-fig-0003" src="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus control, Outcome 1 Improvement in impairment after 12 weeks excluding those who did not complete the study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/references#CD002062-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002062-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/urn:x-wiley:14651858:media:CD002062:CD002062-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_t/tCD002062-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus control, Outcome 2 Improvement in impairment after 12 weeks including those who did not complete the study." data-id="CD002062-fig-0004" src="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus control, Outcome 2 Improvement in impairment after 12 weeks including those who did not complete the study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/references#CD002062-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002062-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/urn:x-wiley:14651858:media:CD002062:CD002062-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_t/tCD002062-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus control, Outcome 3 Number of patients improved after 12 weeks excluding those who did not complete the study." data-id="CD002062-fig-0005" src="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus control, Outcome 3 Number of patients improved after 12 weeks excluding those who did not complete the study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/references#CD002062-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002062-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/urn:x-wiley:14651858:media:CD002062:CD002062-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_t/tCD002062-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus control, Outcome 4 Number of patients who showed improvement after 12 weeks including those who did not complete the study." data-id="CD002062-fig-0006" src="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus control, Outcome 4 Number of patients who showed improvement after 12 weeks including those who did not complete the study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/references#CD002062-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002062-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/urn:x-wiley:14651858:media:CD002062:CD002062-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_t/tCD002062-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone, Outcome 1 Remission at 12 months." data-id="CD002062-fig-0007" src="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone, Outcome 1 Remission at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/references#CD002062-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002062-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/urn:x-wiley:14651858:media:CD002062:CD002062-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_t/tCD002062-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone, Outcome 2 ≥ 1 point improvement on INCAT disability score at 12 months." data-id="CD002062-fig-0008" src="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone, Outcome 2 ≥ 1 point improvement on INCAT disability score at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/references#CD002062-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002062-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/urn:x-wiley:14651858:media:CD002062:CD002062-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_t/tCD002062-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone, Outcome 3 Change in MRC sum score at endpoint." data-id="CD002062-fig-0009" src="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone, Outcome 3 Change in MRC sum score at endpoint. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/references#CD002062-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002062-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/urn:x-wiley:14651858:media:CD002062:CD002062-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_t/tCD002062-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone, Outcome 4 Change in grip strength at endpoint." data-id="CD002062-fig-0010" src="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone, Outcome 4 Change in grip strength at endpoint. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/references#CD002062-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002062-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/urn:x-wiley:14651858:media:CD002062:CD002062-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_t/tCD002062-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone, Outcome 5 Sleeplessness." data-id="CD002062-fig-0011" src="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone, Outcome 5 Sleeplessness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/references#CD002062-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002062-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/urn:x-wiley:14651858:media:CD002062:CD002062-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_t/tCD002062-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone, Outcome 6 Cushingoid facies." data-id="CD002062-fig-0012" src="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone, Outcome 6 Cushingoid facies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/references#CD002062-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002062-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/urn:x-wiley:14651858:media:CD002062:CD002062-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_t/tCD002062-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone, Outcome 7 Weight gain 1 ‐ 3 kg." data-id="CD002062-fig-0013" src="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone, Outcome 7 Weight gain 1 ‐ 3 kg. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/references#CD002062-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002062-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/urn:x-wiley:14651858:media:CD002062:CD002062-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_t/tCD002062-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone, Outcome 8 Weight gain &gt; 3 kg." data-id="CD002062-fig-0014" src="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone, Outcome 8 Weight gain &gt; 3 kg. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/references#CD002062-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/media/CDSR/CD002062/image_n/nCD002062-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD002062-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Prednisone for chronic inflammatory demyelinating polyradiculoneuropathy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Prednisone for chronic inflammatory demyelinating polyradiculoneuropathy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with chronic inflammatory demyelinating polyradiculoneuropathy<br/> <b>Settings:</b> hospital specialist neurological outpatient department<br/> <b>Intervention:</b> prednisone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk or value</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk or value</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control (no treatment)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Prednisone</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Change in disability after one year</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in impairment after 12 weeks (excluding those who did not complete the study)</b><br/> NIS score (range 0 to 280) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean improvement in impairment after 12 weeks, excluding those who did not complete the study in the control group was<br/> 3.5 points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean improvement in impairment after 12 weeks, excluding those who did not complete the study in the prednisone group was<br/> <b>17.14 points higher</b><br/> (4.39 lower to 38.67 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in impairment after 12 weeks (including those who did not complete the study)</b><br/> NIS (range 0 to 280) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean improvement in impairment after 12 weeks, including those who did not complete the study in the control group was<br/> ‐ 2.4 points (i.e. 2.4 points worse) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean improvement in impairment after 12 weeks, including those who did not complete the study in the prednisone group was<br/> <b>11.6 points higher</b><br/> (9.39 lower to 32.58 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants improved after 12 weeks (excluding those who did not complete the study)</b><br/> NIS score (range 0 to 280) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>357 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>857 per 1000</b><br/> (411 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.40</b> <br/> (CI 1.15 to 5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statistically significant more improvement, but at high risk of bias</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants improved after 12 weeks (including those who did not complete the study)</b><br/> NIS (range 0 to 280) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>312 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>631 per 1000</b><br/> (281 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.02</b> <br/> (CI 0.9 to 4.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>NIS</b> : Neuropathy Impairment Scale; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded the quality of evidence three times: twice for very serious study limitations and once for imprecision. The trial was not blinded and randomisation was not concealed. The 95% CI were wide. <br/> <sup>2</sup>Seven participants were excluded, giving high risk of bias in favour of prednisone. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Prednisone for chronic inflammatory demyelinating polyradiculoneuropathy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/full#CD002062-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD002062-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Monthly pulsed high‐dose dexamethasone compared to oral prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Monthly pulsed high‐dose dexamethasone compared to oral prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with chronic inflammatory demyelinating polyradiculoneuropathy<br/> <b>Settings:</b> hospital specialist neurological outpatient department<br/> <b>Intervention:</b> monthly pulsed high‐dose dexamethasone<br/> <b>Comparison:</b> oral prednisolone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk or value</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk or value</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Oral prednisolone</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Monthly pulsed high‐dose dexamethasone</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Change in disability after one year</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Remission at 12 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>375 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>416 per 1000</b><br/> (188 to 919) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.11</b> <br/> (CI 0.5 to 2.45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>≥ 1 point improvement on INCAT disability score at 12 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>438 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>542 per 1000</b><br/> (280 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.24</b> <br/> (CI 0.64 to 2.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in impairment: change in MRC sum score at endpoint4</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in the oral prednisolone group was a 1.6 (SD 6.84) point increase</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in MRC sum score with</p> <p>monthly high‐dose dexamethasone was</p> <p><b>2.4 higher</b> (1.9 lower to 6.7 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>3</sup><br/> Low </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in impairment: change in grip strength at endpoint<sup>4</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in the oral prednisolone group was a 13.4 (SD 38.53) kPa increase</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in grip strength with</p> <p>monthly high‐dose dexamethasone was</p> <p><b>5.3 kPa lower</b> (28.43 lower to 17.83 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not significant</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sleeplessness</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>750 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>330 per 1000</b><br/> (180 to 630) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.44</b> <br/> (CI 0.24 to 0.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>6</sup>Low </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significantly less with</p> <p>monthly high‐dose dexamethasone</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Moon facies</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>688 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>330 per 1000</b><br/> (172 to 639) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.48</b> <br/> (CI 0.25 to 0.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>7</sup><br/> Moderate </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significantly less with</p> <p>monthly high‐dose dexamethasone</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>INCAT</b> : Inflammatory Neuropathy Cause and Treatment; <b>MRC</b> : Medical Research Council; <b>RR:</b> risk ratio; <b>SD</b>: standard deviation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by one, for imprecision. The data are from a single study, which did not achieve planned recruitment, had a small sample size and 95% CI are wide.<br/> <sup>2</sup>Downgraded twice, for imprecision and indirectness. The data are from a single study, which did not achieve planned recruitment, had a small sample size and 95% CI are wide. The INCAT score is not a linear scale.<br/> <sup>3</sup>Downgraded twice, for imprecision and indirectness. The data are from a single study, which did not achieve planned recruitment, had a small sample size and 95% CI are wide; also, the MRC sum is not a linear scale.<br/> <sup>4</sup>The endpoint was 12 months or premature cessation of treatment if after 8 weeks if there had been worsening or no stabilisation, or if there was a relapse back to baseline state, or if there were serious side‐effects due to the drug.<br/> <sup>5</sup>Downgraded by one for imprecision. The data are from a single study, which did not achieve planned recruitment, had a small sample size and 95% CI are wide (imprecision). Grip strength is a linear and direct measure so we did not downgraded a second time.<br/> <sup>6</sup>Downgraded twice, for serious imprecision and indirectness. The data are from a single study, which did not achieve planned recruitment, had a small sample size and 95% CI are wide. Sleeplessness is a subjective outcome caused by many factors.<br/> <sup>7</sup>Downgraded by one for imprecision. The data are from a single study, which did not achieve planned recruitment, had a small sample size and 95% CI are wide. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Monthly pulsed high‐dose dexamethasone compared to oral prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/full#CD002062-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002062-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Corticosteroids versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Improvement in impairment after 12 weeks excluding those who did not complete the study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>17.14 [‐4.39, 38.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Improvement in impairment after 12 weeks including those who did not complete the study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.60 [‐9.39, 32.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of patients improved after 12 weeks excluding those who did not complete the study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.4 [1.15, 5.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number of patients who showed improvement after 12 weeks including those who did not complete the study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.02 [0.90, 4.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Corticosteroids versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/references#CD002062-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002062-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Remission at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.50, 2.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 ≥ 1 point improvement on INCAT disability score at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.64, 2.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Change in MRC sum score at endpoint <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.4 [‐1.90, 6.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Change in grip strength at endpoint <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.30 [‐28.43, 17.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Sleeplessness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.24, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Cushingoid facies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.21, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Weight gain 1 ‐ 3 kg <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.55, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Weight gain &gt; 3 kg <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Standard‐dose daily oral prednisolone versus monthly pulsed high‐dose dexamethasone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002062.pub4/references#CD002062-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD002062.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD002062-note-0001">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD002062-note-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="ru#CD002062-note-0007">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD002062-note-0002">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002062\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002062\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002062\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002062\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002062\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002062\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002062\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002062\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002062\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002062\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002062\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002062\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002062\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002062\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002062\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002062\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002062\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002062\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Qh5938oe&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002062.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD002062.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD002062.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD002062.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002062.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726741710"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD002062.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726741714"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD002062.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e9b0ebd029368',t:'MTc0MDcyNjc0My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 